Sysmex America, Henry Schein sign three-year distribution agreement

Sysmex America, Inc., a global leader in medical diagnostic testing equipment and information systems technology, and Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today announced the signing of a three-year distribution agreement between the companies effective immediately.  Under the agreement, Henry Schein will represent Sysmex's pocH-100i™, XP-300™, XN-1000™, XN-2000™, XS-1000i™ and the XT-4000i™ automated hematology analyzers in the alternate care setting,

"Like Sysmex America, Henry Schein is fully committed to serving customers with the highest level of service and support," said Andy Hay, Vice President of Sales, Sysmex America.  "This commitment, coupled with Henry Schein's excellent local coverage across the U.S., enables our customers with quick access to high-quality hematology analyzers that are supported by high-quality service, support and training.  We look forward to a long-term working relationship with Henry Schein."

"As a market leader in clinical laboratory diagnostics and services, we know that Sysmex America manufactures reliable and easy-to-use hematology analyzers.  This combination is the right fit for our non-acute care customer base," said Dominick Gallo, VP, Product Management, Henry Schein. "The agreement gives us an opportunity to offer an even broader portfolio of onsite lab testing, enabling customers to diagnose and treat patients in the office, greatly improving the patient experience and expediting care."

All of Sysmex's hematology product offerings covered under the Henry Schein distribution agreement include standard support service, on-site installation and training.